Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Synthetic indole compound effective against multidrug resistant tumors in vivo

Aug. 4, 2004

New tubulin polymerization inhibitors covered by Cytopia patent

Aug. 4, 2004

New cinnoline-based antitumor agents in early development at Nippon Kayaku

Aug. 4, 2004

Louisiana State University and Bionomics enter cancer gene therapy agreement

Aug. 3, 2004

Gemzar combination therapy receives European approvals for ovarian cancer

Aug. 2, 2004

Novel HDAC inhibitors in early development at Roche

Aug. 2, 2004

Antitumor colchicine derivatives prepared at Aventis

Aug. 2, 2004

Photodynamic therapy with Metvix shows efficacy in actinic cheilitis

July 30, 2004

Assessment of Bcl -2 family members as targets for antisense therapy in melanoma

July 30, 2004

Plantacor licenses preclinical cancer therapeutics from M. D. Anderson

July 30, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 13, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...